Reports on Alliance Pharmaceuticals' withdrawal from PFC Therapeutics, its joint venture with Baxter Healthcare. Alliance Pharmaceuticals' development of Oxygent, an artificial oxygen carrier; Funding dispute with Baxter; Performance of Oxygent in a phase 2 clinical trial in Europe to assess its use in general surgery.